TTS Pharma is a UK-based pioneer in the production and development of legal cannabinoids, focused on delivering the highest standards in quality, safety, and compliance.
Drawing on our expertise in drug discovery, pharmaceutical development, separation science and purification, we have developed proprietary techniques for the extraction and manufacture of cannabinoid-based products. Our extracts are derived from organically grown hemp biomass sourced from EU-approved seed varieties, ensuring a clean, consistent, and legally compliant supply.
We apply pharmaceutical grade standards throughout our operations to produce high-purity cannabinoids such as Cannabidiol (CBD) for use in food supplements and cosmetics.
TTS Pharma was the first UK company to submit a Novel Food application to the Food Standards Agency (FSA), with our dossier (RP521) now validated and under final sign-off with the UK government. This submission represents one of the most comprehensive CBD safety dossiers currently in the UK market and underpins our entire range of compliant products.
All our products offer full supply chain traceability and are supported by dedicated product liability insurance. Every finished product is tested in accredited laboratories that meet UK government standards, giving our customers confidence in the quality, safety, and legal status of what they buy.
Registered Office: Liverpool Science Park, 131 Mount Pleasant, Liverpool, L3 5TF